Potential use of gelcasting hydroxyapatite porous ceramic as an implantable drug delivery system

被引:90
作者
Netz, DJA
Sepulveda, P
Pandolfelli, VC
Spadaro, ACC
Alencastre, JB
Bentley, MVLB
Marchetti, JM
机构
[1] Univ Sao Paulo, Fac Ciencias Farmaceut Ribeirao Preto, Dept Ciencias Farmaceut, BR-14040903 Ribeirao Preto, SP, Brazil
[2] Univ Fed Sao Carlos, Dept Mat Engn, BR-13565905 Sao Carlos, SP, Brazil
基金
巴西圣保罗研究基金会;
关键词
hydroxyapatite; porous ceramic; implantable drug delivery systems; gelcasting;
D O I
10.1016/S0378-5173(00)00659-1
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Hydroxyapatite (HA) ceramic in a porous configuration is suggested as a drug release system. A new technique for the production of this material, based on the foaming of suspensions and in situ polymerization (gelcasting method), resulted in a material whose characteristics are likely to make it useful as an implantable drug delivery system. Three batches of HA ceramic with different porosities were characterized by X-ray diffraction and scanning electron microscopy (SEM), Pore size and shape as well as density were determined. In vitro experiments were performed in order to evaluate the dissolution behavior of cisplatin in the system. X-ray diffraction analysis showed that the final product consisted of a single phase, indicating that the sintering process had not affected the structure of the HA. Energy dispersive X-ray analysis (EDX) showed absence of impurities. Pore diameters were in the range 15-34 mum. SEM showed that the material presented a highly interconnected spheroidal porous network with open micropores and closed macropores. In vitro experiments showed significant differences in the release rate of cisplatin between three different porosities. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:117 / 125
页数:9
相关论文
共 43 条
[1]   CHEMISTRY AND SINTERING BEHAVIOR OF THIN HYDROXYAPATITE CERAMICS WITH CONTROLLED POROSITY [J].
ARITA, IH ;
WILKINSON, DS ;
MONDRAGON, MA ;
CASTANO, VM .
BIOMATERIALS, 1995, 16 (05) :403-408
[2]   SUSTAINED-RELEASE OF FERROUS SULFATE FROM POLYMER-COATED GUM ARABICA PELLETS [J].
BATRA, V ;
BHOWMICK, A ;
BEHERA, BK ;
RAY, AR .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1994, 83 (05) :632-635
[3]   Hydroxyapatite-gelatin films: a structural and mechanical characterization [J].
Bigi, A ;
Panzavolta, S ;
Roveri, N .
BIOMATERIALS, 1998, 19 (7-9) :739-744
[4]   STRUCTURE DEVELOPMENT STUDIES DURING MATERIALS PROCESSING [J].
BRAS, W ;
DERBYSHIRE, GE ;
BOUWSTRA, JA ;
OVERSLUIZEN, M ;
DOKTER, W .
NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION B-BEAM INTERACTIONS WITH MATERIALS AND ATOMS, 1995, 97 (1-4) :257-260
[5]  
CALHOUN JH, 1997, CLIN ORTHOP RELAT R, V341, P206
[6]   Cumulative toxicities from cisplatin therapy and current cytoprotective measures [J].
Cvitkovic, E .
CANCER TREATMENT REVIEWS, 1998, 24 (04) :265-281
[7]   Intravitreal sustained-release ganciclovir implantation to control cytomegalovirus retinitis in AIDS [J].
Dhillon, B ;
Kamal, A ;
Leen, C .
INTERNATIONAL JOURNAL OF STD & AIDS, 1998, 9 (04) :227-230
[8]   HYDROXYAPATITE-BASED POROUS AGGREGATES - PHYSICOCHEMICAL NATURE, STRUCTURE, TEXTURE AND ARCHITECTURE [J].
FABBRI, M ;
CELOTTI, GC ;
RAVAGLIOLI, A .
BIOMATERIALS, 1995, 16 (03) :225-228
[9]   Influence of temperature and additives on the microstructure and sintering behaviour of hydroxyapatites with different Ca/P ratios [J].
Fanovich, MA ;
Lopez, JMP .
JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE, 1998, 9 (01) :53-60
[10]  
HAGIWARA A, 1993, CANCER-AM CANCER SOC, V71, P844, DOI 10.1002/1097-0142(19930201)71:3<844::AID-CNCR2820710330>3.0.CO